NADAC acquisition cost data for LUNESTA 3 MG TABLET. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 63402019303 | $19.10 | 2022-12-16 | Rx |
| 63402019303 | $19.10 | 2022-12-16 | Rx |
Generic: Eszopiclone | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $6.5M | 11,217 | 1,776 | $15.66 |
| 2020 | $5.7M | 9,617 | 1,485 | $15.60 |
| 2021 | $5.5M | 9,206 | 1,472 | $15.76 |
| 2022 | $4.9M | 8,173 | 1,320 | $16.06 |
| 2023 | $5.9M | 7,117 | 1,180 | $22.44 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $1.1M | 1,610 | 210 |
| California | $637.9K | 727 | 126 |
| Florida | $475.2K | 542 | 98 |
| New Jersey | $310.1K | 376 | 68 |
| Massachusetts | $286.6K | 311 | 58 |
| Texas | $279.1K | 322 | 72 |
| Pennsylvania | $266.0K | 298 | 56 |
| Minnesota | $157.7K | 192 | 27 |
| South Carolina | $154.8K | 179 | 36 |
| Ohio | $151.7K | 220 | 32 |
| Illinois | $140.0K | 132 | 33 |
| Michigan | $134.5K | 132 | 25 |
| Georgia | $127.9K | 162 | 25 |
| North Carolina | $121.8K | 131 | 29 |
| Wisconsin | $115.8K | 173 | 20 |
| Tennessee | $101.4K | 141 | 17 |
| Connecticut | $96.2K | 93 | 23 |
| Maryland | $91.2K | 96 | 23 |
| Arizona | $81.9K | 118 | 18 |
| Indiana | $81.0K | 77 | 15 |
| Washington | $76.7K | 67 | 13 |
| Colorado | $62.6K | 81 | 14 |
| Virginia | $55.1K | 69 | 17 |
| Kentucky | $51.6K | 63 | 13 |
| Missouri | $48.8K | 52 | 11 |
| Louisiana | $47.6K | 65 | 14 |
| Oregon | $44.3K | 33 | N/A |
| Nevada | $43.2K | 63 | N/A |
| Alaska | $42.9K | 28 | N/A |
| Rhode Island | $41.1K | 48 | N/A |
| Hawaii | $39.6K | 45 | N/A |
| Nebraska | $34.6K | 26 | N/A |
| South Dakota | $34.1K | 35 | N/A |
| Utah | $30.4K | 33 | N/A |
| Vermont | $29.8K | 42 | N/A |
| Iowa | $29.0K | 17 | N/A |
| Oklahoma | $28.2K | 31 | N/A |
| New Mexico | $28.1K | 35 | N/A |
| Alabama | $26.4K | 32 | N/A |
| Idaho | $25.6K | 29 | N/A |
| West Virginia | $24.6K | 39 | N/A |
| Maine | $22.3K | 26 | N/A |
| Arkansas | $17.7K | 28 | N/A |
| Kansas | $17.5K | 23 | N/A |
| Mississippi | $15.9K | 26 | N/A |
| Delaware | $12.1K | 11 | N/A |
| Wyoming | $8.7K | 12 | N/A |
| New Hampshire | $7.3K | 12 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.